search button
Open Access

Regulation of the p53‑mediated ferroptosis signaling pathway in cerebral ischemia stroke (Review)

  • Authors:
    • Shuangli Xu
    • Xuewei Li
    • Yanqiang Wang

  • View Affiliations

  • Published online on: January 26, 2023     https://doi.org/10.3892/etm.2023.11812
  • Article Number: 113

  • Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Stroke is one of the most threatening diseases worldwide, particularly in countries with larger populations; it is associated with high morbidity, mortality and disability rates. As a result, extensive research efforts are being made to address these issues. Stroke can include either hemorrhagic stroke (blood vessel ruptures) or ischemic stroke (blockage of an artery). Whilst the incidence of stroke is higher in the elderly population (≥65), it is also increasing in the younger population. Ischemic stroke accounts for ~85% of all stroke cases. The pathogenesis of cerebral ischemic injury can include inflammation, excitotoxic injury, mitochondrial dysfunction, oxidative stress, ion imbalance and increased vascular permeability. All of the aforementioned processes have been extensively studied, providing insights into the disease. Other clinical consequences observed include brain edema, nerve injury, inflammation, motor deficits and cognitive impairment, which not only cause disabilities obstructing daily life but also increase the mortality rates. Ferroptosis is a type of cell death that is characterized by iron accumulation and increased lipid peroxidation in cells. In particular, ferroptosis has been previously implicated in ischemia‑reperfusion injury in the central nervous system. It has also been identified as a mechanism involved in cerebral ischemic injury. The tumor suppressor p53 has been reported to modulate the ferroptotic signaling pathway, which both positively and negatively affects the prognosis of cerebral ischemia injury. The present review summarizes the recent findings on the molecular mechanisms of ferroptosis under the regulation of p53 underlying cerebral ischemia injury. Understanding of the p53/ferroptosis signaling pathway may provide insights into developing methods for improving the diagnosis, treatment and even prevention of stroke.
View Figures
View References

Related Articles

Journal Cover

March-2023
Volume 25 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.4
  • Ranked Medicine Research and Experimental
    (total number of cites)
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Xu S, Li X and Wang Y: Regulation of the p53‑mediated ferroptosis signaling pathway in cerebral ischemia stroke (Review). Exp Ther Med 25: 113, 2023.
APA
Xu, S., Li, X., & Wang, Y. (2023). Regulation of the p53‑mediated ferroptosis signaling pathway in cerebral ischemia stroke (Review). Experimental and Therapeutic Medicine, 25, 113. https://doi.org/10.3892/etm.2023.11812
MLA
Xu, S., Li, X., Wang, Y."Regulation of the p53‑mediated ferroptosis signaling pathway in cerebral ischemia stroke (Review)". Experimental and Therapeutic Medicine 25.3 (2023): 113.
Chicago
Xu, S., Li, X., Wang, Y."Regulation of the p53‑mediated ferroptosis signaling pathway in cerebral ischemia stroke (Review)". Experimental and Therapeutic Medicine 25, no. 3 (2023): 113. https://doi.org/10.3892/etm.2023.11812